Concepedia

Fabio Galli

FG

25

Publications

1.1K

Citations

19

H-Index

2004

Active since

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

Mario Negri Institute for Pharmacological Research

Ospedale Papa Giovanni XXIII

Istituto Ortopedico Galeazzi

Ospedale Policlinico San Martino

Fabio Galli is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in colorectal cancer, oncology, and botany.

ORCID

Top concepts

Publications per year

2004–2022

25

Publications

25

Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer

Timothy Iveson, Alberto Sobrero, Takayuki Yoshino et al. · Journal of Clinical Oncology · 2021 · 98 citations · Full text

Effectiveness of prophylactic antibiotics at placement of dental implants: a pragmatic multicentre placebo-controlled randomised clinical trial.

Marco Esposito, Gioacchino Cannizzaro, Paolo Bozzoli et al. · PubMed · 2010 · 89 citations

Immediate non‐occlusal vs. early loading of dental implants in partially edentulous patients: a multicentre randomized clinical trial. Peri‐implant bone and soft‐tissue levels

Fabio Galli, Matteo Capelli, Francesco Zuffetti et al. · Clinical Oral Implants Research · 2008 · 78 citations

Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients

Annamaria Ruzzo, Francesco Graziano, Fabio Galli et al. · British Journal of Cancer · 2017 · 68 citations · Full text

Immediate nonocclusal versus early loading of dental implants in partially edentulous patients: 1-year results from a multicenter, randomized controlled clinical trial.

Tiziano Testori, Fabio Galli, Matteo Capelli et al. · PubMed · 2007 · 65 citations

Rows per page

1–5 of 25